ABVC Biopharma Inc (ABVC) support and resistance · rev $509.6K
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
This page maps ABVC Biopharma Inc (ABVC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ABVC revenue for 2024-12-31 was $509.6K. Net income was -$5.3M. Revenue was up 234.3% from 2023-12-31 to 2024-12-31. ABVC currently screens at market cap $35.9M.
ABVC currently screens at market cap $35.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ABVC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ABVC quote page for the session range and the stock page for the full model.
Not investment advice.